When Evusheld is available in the U.S., there is one big problem: where do you go to get it. Fortunately, there is a hospital in La Grande, Ore., that offers the drug and enrolled her as a patient. After requesting a series of shots, she drove 11 hours to get the drug. While her medical education and wealth allow her to take time off for this, many health workers had never heard of the drug and had no idea when Evusheld would be available in the U.S.
Regeneron, a company in California, has a vaccine for Covid-19 called Evusheld. The company had fought the HHS for years to gain access to monoclonal antibodies that target the Omicron variant. The FDA has granted the company approval, but HHS has rejected Regeneron’s request for expanded emergency use authorization. Meanwhile, a kidney transplant recipient from Massachusetts recently became the first person in the US to get the vaccine, after calling around for two weeks. Since then, she’s helped others navigate the process.
While the FDA has approved Covid, it has not been approved for the drug. Regeneron has requested that its emergency use authorization be expanded so that the drug can be offered to immunocompromised patients. However, HHS says that it is unlikely Regeneron will retain its activity against the Omicron variant. As a result, patients must wait for the drug to become available. Those with immune-compromised systems will have to make the difficult decision of whether to get the vaccine or wait for Evusheld.
Although the FDA has approved Evusheld for COVID-19, it’s still not available in many hospitals. People with immunocompromised immune systems have turned to online communities for help. In January, Dr. Vivian G. Cheung of the University of Maryland Medical Center found a clinic that had Evusheld and started helping others navigate the system. She’s been a patient since January and is helping other patients find the drug.
As a result of the shortage, many people are searching for Evusheld in their area. For example, Dr. Mallett found a pharmacy in Cincinnati that offered the drug. Then, she faxed her notes to the various hospitals. She discovered that the University of Maryland hospital was the one with the highest doses. Ultimately, she was able to get the drug after two weeks of cold calling pharmacies and hospitals.
When Evusheld is available in the United States? The drug is not available in every state, but some hospitals have a small supply. Some hospitals have a few hundred bottles of the medicine, while others don’t. This means that the drug may be inaccessible to many patients in some states. For this reason, it is important to have a physician’s recommendation. It is recommended that you seek medical assistance for Evusheld, as it is not a substitute for the vaccine.
For those who don’t have access to the drug, the U.S. government has purchased the drug and is distributing it to individual states. The drug will be allocated to these states in the coming months, and patients can choose where to get it. This drug is still not available in all parts of the country, but it is available in other countries. If you can find it in the U.S., it can help you live a normal life with Evusheld.
Not everyone has access to the drug. In Cincinnati, the only hospital near her home offers it to transplant patients. But the other hospital won’t accept outside patients. Her son has already had two vaccinations in the past. So, she had to call different hospitals in the region in order to get the drug. But despite her limited financial resources, she still has no access to the drug. This is not an easy situation to handle.
The availability of the drug is another problem. The US Centers for Disease Control and Prevention track the vaccines given to the immune-compromised. The vaccine is only available to immunocompromised adolescents aged 12 to 17 years old, and it is only available to those who qualify. For most patients, Evusheld is not a substitute for the COVID-19 vaccine. Those who are immune-compromised can still get the drug.